Abstract
Statins have been commonly used to treat patients with hypercholesterolaemia and to prevent cardiovascular disease (CVD) worldwide. This study examined trends in use of statins in Taiwan from 2002 to 2011. This is a retrospective observational study focusing on the utilisation of statins. The monthly claims data for statins between 2002 and 2011 were retrieved from Taiwan's National Health Insurance Research Database. We calculated the yearly prescription rate per new user for each statin. Products were classified as high-intensity/moderate-intensity/low-intensity statins by type of statin and dosage. Users were also classified based on disease histories. The number of statin users increased from 10 299 (~1.4% of adults) in 2002 to 50 687 (~6.3% of adults) in 2011. Atorvastatin was the most commonly used agent (28.4%-36.7%) during the study period. After 2007, simvastatin ranked second with 21.7% market share, followed by rosuvastatin, a newer agent that exhibited a substantial growth in prescription rates (3.4% in 2005 and 19.5% in 2011). In 2011, 94.0% of new statin users used statin monotherapies, and 6.0% used combination therapies. Use of moderate-intensity statins increased from 49.0% in 2002 to 71.0% in 2011, while high-...Continue Reading
Citations
Nov 28, 2018·Current Medical Research and Opinion·Jun-Jun YehChia-Hung Kao
Mar 6, 2018·Journal of Public Health·Feng-Jen Tsai, Valérie Junod
Dec 21, 2019·Biomédica : revista del Instituto Nacional de Salud·Andres Gaviria-MendozaJorge E Machado-Alba
Dec 18, 2019·The Clinical Respiratory Journal·Wei-Sheng Chung, Cheng-Li Lin
Mar 8, 2019·BMJ Open·Kyung-Bok Son, SeungJin Bae
Sep 18, 2020·American Journal of Men's Health·H M WangT T Guo
Aug 2, 2017·Bioscience Reports·Bin ChenYu Feng
May 24, 2018·Cardiovascular Drugs and Therapy·Richard Ofori-AsensoDanny Liew
Sep 3, 2019·Frontiers in Pharmacology·Jun-Jun YehChia-Hung Kao
Aug 7, 2020·Journal of Primary Care & Community Health·Andrés Gaviria-MendozaJorge Enrique Machado-Alba
Oct 28, 2019·Journal of Evaluation in Clinical Practice·Wen-Jone ChenFei-Yuan Hsiao
May 10, 2020·Scientific Reports·I-Gung LiYuan-Hsiung Tsai
Sep 5, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Kyung-Bok Son
Oct 26, 2018·Journal of Clinical Medicine·Jun-Jun YehChia-Hung Kao
Apr 27, 2020·BMC Cardiovascular Disorders·Yujuan LiuJun Zhang
Nov 13, 2020·Journal of Clinical Pharmacy and Therapeutics·Chia-Yun HsuFei-Yuan Hsiao
Dec 18, 2020·Rheumatology·Yu-Hao XueJames Cheng-Chung Wei
Jan 15, 2021·BMJ Open·Tzu-Tsen KuoChing-Jung Hsieh
Jun 11, 2021·Current Problems in Cardiology·Stella TalicElla Zomer
Jun 7, 2021·Atherosclerosis·Joseph E BlaisEsther W Chan
Jul 1, 2021·Scientific Reports·Jing-Hung FangChia-Chun Wu
Aug 25, 2021·Scientific Reports·Chao-Ping ChenWen-Chen Tsai